Results 181 to 190 of about 191,512 (263)

T(w)o Patch or Not T(w)o Patch: A Novel Biocontrol Model

open access: yesMathematical Methods in the Applied Sciences, EarlyView.
ABSTRACT A number of top‐down biocontrol models have been proposed where the introduced predators' efficacy is enhanced via the provision of additional food (AF). However, if the predator has a pest‐dependent monotone functional response, pest extinction is unattainable. In the current manuscript, we propose a model where a predator with pest‐dependent
Urvashi Verma   +2 more
wiley   +1 more source

HIV Prevention Today [PDF]

open access: yes
In the United States, it is estimated that prevention efforts have already averted more than 350,000 HIV infections.Since the height of the epidemic in the mid-1980s, the annual number of new HIV infections in the United States has been reduced by more ...

core  

Endoscopic small bowel therapies for type 2 diabetes

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Type 2 diabetes is a global epidemic despite current medical treatments. Many patients are not responsive to medications, and patients with obesity are hesitant about bariatric surgery. Studies investigating the metabolic effects of Roux‐en‐Y gastric bypass have increasingly demonstrated that the duodenum plays a key role in the ...
Roma Patel   +4 more
wiley   +1 more source

Turning the tide of the epidemic [PDF]

open access: yes
For 30 years CDC has played a leading role in achieving scientific progress and translating science into action to save millions of lives in the global fight against HIV/AIDS.Recent scientific advances now offer a historic new opportunity \u2013 using ...

core  

Evaluating the Evolving Real‐World Adverse Events of GLP‐1RAs Using FDA Adverse Event Reporting System (FAERS)

open access: yesObesity, EarlyView.
Web portal for interrogating Adverse Events of GLP‐1 RA in diabetes vs weight control/obesity. ABSTRACT Objective This study aimed to assess the spectrum and frequency of adverse events (AEs) linked to glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) using the US FDA Adverse Event Reporting System (FAERS).
David Stone   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy